Skip to main content
. Author manuscript; available in PMC: 2019 Apr 20.
Published in final edited form as: Leukemia. 2018 Jul 19;33(1):171–180. doi: 10.1038/s41375-018-0205-y

Fig. 1.

Fig. 1

Genome-scale CRISPR-Cas9 screen identifies genes essential for pomalidomide-induced cytotoxicity in MM.1S cells. a Flowchart of pomalidomide resistance screening. Poma pomalidomide. b A sample list of top ranked genes. c Enrichment of specific sgRNAs after Poma treatment. Each dot specifies one sgRNA